Evidence map›Paper›PMID 25172115›Full record

Trial reportSleep medicine2014

Increases in duration of first uninterrupted sleep period are associated with improvements in PSQI-measured sleep quality.

Donald L Bliwise, Tove Holm-Larsen, Sandra Goble

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Sleep medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00477490 (A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multi-Center Study With a Double Blind Extension Investigating the Efficacy and Safety of a Fast- Dissolving), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00477490 phase3completednot on this map

A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multi-Center Study With a Double Blind Extension Investigating the Efficacy and Safety of a Fast- Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults

TypeinterventionalSponsorFerring PharmaceuticalsRan2007 to 2008Enrolled799ConditionsNocturiaArmsdesmopressin acetate, Placebo
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Overnight Urge Perception in Nocturia Is Independent of Depression, PTSD, or Anxiety in a Male Veterans Administration Population.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2019
    Article
  10. Article
  11. Association of the combination of sleep duration and sleep quality with quality of life in type 2 diabetes patients.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2018
    Article
  12. Article
  13. Nocturia: aetiology and treatment in adults.Nature reviews. Urology · 2016
    Review
  14. Nocturia: The circadian voiding disorder.Investigative and clinical urology · 2016
    Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Donald L BliwiseProgram in Sleep Medicine, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: dbliwis@emory.edu.
Tove Holm-LarsenDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Sandra GobleGlobal Research and Development, Ferring Pharmaceuticals, Copenhagen, Denmark.
Emory University · USFerring Pharmaceuticals (Denmark) · DKUniversity of Copenhagen · DK

Funding

Sleep/Wake Contiuum in Lewy Body DiseaseR01NS050595 · NINDS · EMORY UNIVERSITY · PI BLIWISE, DONALD L. · 2006 to 2010
$1.7M
NINDS NIH HHS NS-050595NINDS NIH HHS R01 NS050595
6 · The paper itself

Abstract

objectiveUrology clinical trials assessing bladder function have relied on the self-reported duration of the first uninterrupted sleep period (FUSP) as a proxy outcome for sleep, but the relationship between this measure and more conventional self-reported measures of sleep is unknown. In this study, we examined the association between changes in FUSP and a widely used self-reported measure of sleep, the Pittsburgh Sleep Quality Index (PSQI).

methodsWe conducted post hoc (secondary) analyses of unpublished data from a previously published randomized clinical trial (NCT00477490) of desmopressin (a medication used to treat nocturia) and examined relationships between baseline and 4-week change in FUSP and PSQI global and subscale scores for participants (N = 580 to N = 606) having complete data.

resultsData indicated strong associations between change in PSQI global score and FUSP change in six of seven subscale scores. A reduction of 1.8 points in the PSQI global score was associated with a 72-min lengthening of FUSP.

conclusionsResults suggest that FUSP is a potentially valuable metric that correlates with changes in perceived sleep duration, depth, quality for the entire night, efficiency, latency, and daytime function. An increase in FUSP was related to improvement in nearly all PSQI subscales. The validity of this measure in the general population remains to be determined.

Indexed as

AdultAgedAged, 80 and overAntidiuretic AgentsDeamino Arginine VasopressinFemaleHumansMaleMiddle AgedNocturiaSleepSleep DeprivationTime FactorsYoung AdultAntidiuretic AgentsDeamino Arginine VasopressinClinical trialFirst uninterrupted sleep periodNocturiaPSQISelf-reportSleep

Identifiers

PMID25172115
PMCPMC4170006
OpenAlexW2029004758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.